Crossmark

Triple therapy of hepatocellular carcinoma with microRNA-122 and doxorubicin co-loaded functionalized gold nanocages

Crossref DOI link: https://doi.org/10.1039/C8TB00224J

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Huang, Shengnan https://orcid.org/0000-0003-2566-4324
Liu, Ying

Xu, Xin

Ji, Mengfei

Li, Yuanmin

Song, Chengjun

Duan, Shaofeng

Hu, Yurong https://orcid.org/0000-0002-0354-7939
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81272563)

Natural Science Foundation of Henan Province (162300410044)
License Information

Accepted Manuscript valid from 2019-03-08
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Shengnan Huang (ORCID)

: Yurong Hu (ORCID)

: Yurong Hu (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 24 January 2018; Accepted 5 March 2018; Accepted Manuscript published 8 March 2018; Advance Article published 3 April 2018; Version of Record published 18 April 2018